Multiple Myeloma Macrophages: Pivotal Players in the Tumor Microenvironment

被引:54
作者
Berardi, Simona [1 ]
Ria, Roberto [1 ]
Reale, Antonia [1 ]
De Luisi, Annunziata [1 ]
Catacchio, Ivana [1 ]
Moschetta, Michele [1 ]
Vacca, Angelo [1 ]
机构
[1] Univ Bari Aldo Moro, Med Sch, Clin Med G Baccelli, Dept Biomed Sci & Human Oncol, Piazza Giulio Cesare 11, I-70124 Bari, Italy
关键词
D O I
10.1155/2013/183602
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor microenvironment is essential for multiple myeloma (MM) growth, progression, and drug resistance through provision of survival signals and secretion of growth and proangiogenic factors. This paper examines the importance of macrophages within MM bone marrow (BM) microenvironment, referred to as MM-associated macrophages, as a potential niche component that supports tumor plasma cells. These macrophages are derived from peripheral blood monocytes recruited into the tumor. Upon activation by MM plasma cells and mesenchymal stromal cells, macrophages can release growth factors, proteolytic enzymes, cytokines, and inflammatory mediators that promote plasma cell growth and survival. Macrophages promote tumor progression through several mechanisms including angiogenesis, growth, and drug resistance. Indeed, these macrophages are essential for the induction of an angiogenic response through vasculogenic mimicry, and this ability proceeds in step with progression of the plasma cell tumors. Data suggest that macrophages play an important role in the biology and survival of patients with MM, and they may be a target for the MM antivascular management.
引用
收藏
页数:6
相关论文
共 40 条
  • [1] A subpopulation of peritoneal macrophages form capillary-like lumens and branching patterns in vitro
    Anghelina, Mirela
    Moldovan, Leni
    Zabuawala, Tahera
    Ostrowski, M. C.
    Moldovan, N. I.
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2006, 10 (03) : 708 - 715
  • [2] Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
    Barleon, B
    Sozzani, S
    Zhou, D
    Weich, HA
    Mantovani, A
    Marme, D
    [J]. BLOOD, 1996, 87 (08) : 3336 - 3343
  • [3] BARONI CD, 1987, HISTOPATHOLOGY, V11, P1029
  • [4] Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators
    Ben-Baruch, A
    [J]. SEMINARS IN CANCER BIOLOGY, 2006, 16 (01) : 38 - 52
  • [5] Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression
    Bissell, Mina J.
    Hines, William C.
    [J]. NATURE MEDICINE, 2011, 17 (03) : 320 - 329
  • [6] Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR-/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma
    Brimnes, M. K.
    Vangsted, A. J.
    Knudsen, L. M.
    Gimsing, P.
    Gang, A. O.
    Johnsen, H. E.
    Svane, I. M.
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 72 (06) : 540 - 547
  • [7] Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
    Condeelis, J
    Pollard, JW
    [J]. CELL, 2006, 124 (02) : 263 - 266
  • [8] Inflammation and cancer
    Coussens, LM
    Werb, Z
    [J]. NATURE, 2002, 420 (6917) : 860 - 867
  • [9] Targeting the bone marrow microenvironment in hematologic malignancies
    Dalton, WS
    Hazlehurst, L
    Shain, K
    Landowski, T
    Alsina, M
    [J]. SEMINARS IN HEMATOLOGY, 2004, 41 (02) : 1 - 5
  • [10] The tumor microenvironment: focus on myeloma
    Dalton, WS
    [J]. CANCER TREATMENT REVIEWS, 2003, 29 : 11 - 19